Page last updated: 2024-09-03

2-(n-myristoylamino)-1-phenyl-1-propanol and n-acetylneuraminic acid

2-(n-myristoylamino)-1-phenyl-1-propanol has been researched along with n-acetylneuraminic acid in 1 studies

Compound Research Comparison

Studies
(2-(n-myristoylamino)-1-phenyl-1-propanol)
Trials
(2-(n-myristoylamino)-1-phenyl-1-propanol)
Recent Studies (post-2010)
(2-(n-myristoylamino)-1-phenyl-1-propanol)
Studies
(n-acetylneuraminic acid)
Trials
(n-acetylneuraminic acid)
Recent Studies (post-2010) (n-acetylneuraminic acid)
23076,736652,248

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aloy, MT; Alphonse, G; Ardail, D; Bionda, C; Rodriguez-Lafrasse, C; Rousson, R1

Other Studies

1 other study(ies) available for 2-(n-myristoylamino)-1-phenyl-1-propanol and n-acetylneuraminic acid

ArticleYear
Overcoming resistance to gamma-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels.
    Oncogene, 2004, Apr-08, Volume: 23, Issue:15

    Topics: Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Caspase 8; Caspase Inhibitors; Caspases; Cell Line, Tumor; Ceramides; Chromatography, High Pressure Liquid; Dose-Response Relationship, Radiation; Enzyme Activation; Flow Cytometry; Gamma Rays; Glucosyltransferases; Glutathione; Head and Neck Neoplasms; Humans; Kinetics; Mitochondria; Mitosis; Myristates; N-Acetylneuraminic Acid; Oxidation-Reduction; Propanolamines; Reactive Oxygen Species; Sphingolipids; Time Factors

2004